HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
0.4933
+0.0150 (3.14%)
At close: Aug 21, 2026, 4:00 PM EDT
0.4831
-0.0102 (-2.07%)
After-hours: Aug 21, 2026, 7:42 PM EDT
Company Description
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms.
HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
HeartBeam, Inc.
| Country | United States |
| Founded | 2015 |
| IPO Date | Nov 11, 2021 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Robert Eno |
Contact Details
Address: 2118 Walsh Avenue, Suite 210 Santa Clara, California 95050 United States | |
| Phone | 408 899 4443 |
| Website | heartbeam.com |
Stock Details
| Ticker Symbol | BEAT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $6.00 |
| CIK Code | 1779372 |
| CUSIP Number | 42238H108 |
| ISIN Number | US42238H1086 |
| Employer ID | 47-4881450 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert P. Eno | Chief Executive Officer and Chief Business Officer |
| Richard M. Ferrari | Executive Chairman |
| Dr. Branislav Vajdic Ph.D. | Founder, President and Director |
| Timothy Cruickshank | Chief Financial Officer |
| Kenneth Persen | Chief System Development Officer |
| Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. | Member of Scientific Advisory Board and Chief Medical Advisor |
| Richa Gujarati | Senior Vice President of Product |
| Dr. Lance Myers Ph.D. | Chief Artificial Intelligence Scientist |
| Bryan Humbarger | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 424B5 | Filing |
| Aug 13, 2026 | SCHEDULE 13D/A | Filing |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 6, 2026 | 8-K/A | [Amend] Current report |
| Aug 3, 2026 | 8-K | Current Report |
| Jul 2, 2026 | 8-K | Current Report |
| Jun 25, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 24, 2026 | 8-K | Current Report |
| Jun 22, 2026 | 8-K | Current Report |